ABSTRACT
I
n adults presenting to the emergency department (ED) with chest pain, the electrocardiogram (ECG) is an essential tool in initial management and risk stratification. The presence of ST-segment elevation greater than 0.1 mV in two contiguous leads, or 0.2 mV in leads V2-V3, identifies those patients who will benefit from urgent reperfusion therapy. 1 Other ECG changes, such as ST-depression, T-wave inversion (TWI), pathological Q-waves, and bundle branch blocks, confer an increased likelihood of non-ST-segment elevation myocardial infarction (NSTEMI) 2, 3 and are used in the ED to risk stratify patients with possible acute coronary syndromes (ACS). However, normal ECGs are seen in up to 8% of patients with an acute myocardial infarction (AMI) and even larger proportions of patients with unstable angina. 2, 4, 5 The third universal definition for myocardial infarction subclassifies AMIs and includes Type 1 and Type 2.
6 Type 1 myocardial infarctions (T1MI) are secondary to unstable coronary artery disease (CAD), typically with associated coronary thrombosis. Type 2 myocardial infarction (T2MI) is defined as an AMI secondary to an ischemic imbalance, where a condition other than CAD contributes to a mismatch between myocardial oxygen supply and demand. Typical conditions commonly seen in the ED associated with T2MI include hypoxemia, shock, and tachycardia. Modern troponin assays, with increasing sensitivity, may lead to more patients being identified with T2MIs. Studies characterizing the ECG changes in patients with T2MI are limited in number and report increased rates of ST-depression and transient STelevation in T2MI when compared with T1MI and lower rates of persistent ST-elevation than T1MI. 7, 8 Modern troponin assays have also led to a greater proportion of chest pain patients having elevated cardiac biomarker values and consequently being diagnosed as NSTEMI. 9, 10 These small infarctions may not cause an ECG disturbance, leading to an increased prevalence of AMI in those with normal or minimally abnormal ECGs. An increased number of patients with ECG normal AMI would render ECG abnormalities less sensitive for detection of AMI. The utility of early findings of ischemia in ECGs in the context of improved troponin assays has yet to be investigated.
In this study we sought to investigate the ECG abnormalities in patients with potential ACS. To aid standardization of clinical interpretation of ECGs, criteria have been reported suggesting a six-point ECG classification system. 11 The utility of this ECG criterion has not been reported in the contemporary era with new troponin assays, nor for the new subclassifications for AMI. 2 We utilized this six-point system and investigated the frequency of 30-day major adverse cardiac events (MACE; including AMI, cardiac death, and unstable angina pectoris) within each category. In addition, we analyzed the frequency of T1MI, T2MI, and 1-year mortality for each ECG category.
METHODS

Study Design
This is a secondary analysis of data from two studies on ED patients with potential ACS. The first was the Australian cohort of the ADAPT trial, 12 a prospective observational study of adult patients presenting to a tertiary ED between November 2008 and January 2011. The second was a nonrandomized interventional trial conducted between February 2011 and July 2013. The intervention was an accelerated diagnostic protocol (ADP), the IMProved Assessment of Chest pain Trial (ImpACT) Protocol. 13 A total of 2,349 patients were enrolled in total, 983 from ADAPT and 1366 from ImpACT. Criteria for enrollment and workup in the first 2 hours were identical between studies. This study, and the original study protocols, were approved by the institutions' human research and ethics committees and complied with the Declaration of Helsinki. Written informed consent was obtained from all participants.
Study Setting and Population
Both studies took place in the ED of a large Australian tertiary care hospital. Patients were enrolled from 8 AM to 5 PM if they were over 18 years of age, were presenting with greater than 5 minutes of pain or discomfort suggestive of ACS, and were being evaluated by the treating clinician for cardiac ischemia. In accordance with American Heart Association case definitions, 14 pain suggestive of ACS included acute chest, epigastric, neck, jaw, or arm pain or discomfort or pressure without an apparent noncardiac source. Research staff identified all eligible patients who presented using the ED admissions database and in collaboration with the treating clinicians. Patients were excluded if they had been transferred from another hospital, were unable to provide consent, were pregnant, had been enrolled in to the study in the past 45 days, were unable to be followed up at 30 days, or had a clear noncardiac cause for their pain. Six patients were excluded from this analysis because they had no zero-hour ECG.
Study Protocol
Methods of data collection have previously been described in detail. 13 Research nurses enrolled patients between 9 AM and 5 PM using standardized reporting criteria. 11 Data on symptoms, past medical history, cardiovascular risk factors, and medications were collected. ECGs and blood samples were collected on presentation and at 2 to 6 hours later. Follow-up of patients was conducted at 30 days and at 1 year for patients consenting to longer follow up. Follow-up was conducted by research nurses through phone interviews, review of all clinical records, and contact with healthcare providers. Mortality data were obtained using local hospital databases and a search of the national death registry.
ECGs were obtained on presentation and at 2 hours. These were used in clinical care and were retrospectively adjudicated by cardiologists blinded to patient identity and all clinical information. ECGs were grouped according to the criteria outlined in Table 1 . Each ECG was included in one category only. The ECGs were categorized according to standardized reporting guidelines 11 to facilitate comparison with previous studies. 2 Dysrhythmias were classified as abnormal but not diagnostic of ischemia. The presentation ECG was the only ECG used in this study.
Key Outcome Measures
The primary outcome was 30-day MACE. MACE included AMI (Type 1 and 2), cardiovascular death, unstable angina pectoris, or revascularization (emergency or urgent). Secondary outcome measures were 30-day T1MI, 30-day T2MI, and 1-year mortality rates. Local cardiologists adjudicated all cases. All cases of MACE and 10% of non-MACE cases were readjudicated by a second cardiologist. In cases of disagreement, endpoints were agreed by consensus. This was achieved for all endpoints. All clinical information was available to the adjudicators, including clinical record, cardiac markers, ECG, and the results of invasive and provocative testing.
Diagnosis of T1MI was according to international guidelines 6 and based on evidence of myocardial necrosis and ischemia. Evidence of ischemia included at least one of the following: ECG changes or positive imaging results from exercise tolerance testing, myocardial perfusion scan, stress echocardiography, computed tomographic coronary angiography, or coronary angiography during catheterization. Necrosis was diagnosed according to an increase or decrease in cardiac troponin concentration during at least 6 hours, with at least one value above the 99th percentile of the normal reference range at a level of assay imprecision near 10%. If the troponin level was greater than the reference range but no increase or decrease was recorded, other causes of increased troponin were considered. If no alternative cause for the troponin increase was apparent, and if the clinical presentation Table 1 Standardized ECG Reporting Criteria as proposed by Cullen et al. 11 
Normal
No possible evidence for ischemia.
Nonspecific ST-T-wave changes
Accepted deviation from the norm, with the lowest likelihood of ischemia (e.g., inverted T-wave axis in III or V1). was suggestive of ACS, an adjudicated diagnosis of AMI was made. In keeping with the third universal definition, 6 T2MI was diagnosed with evidence of cardiac necrosis and where a condition other than CAD contributed to an imbalance between myocardial oxygen supply and/or demand and absence of evidence of coronary ischemia with objective testing (as described above). Diagnosis of unstable angina pectoris was based on ischemic symptoms, ECG changes, and objective investigations (exercise stress testing, stress echocardiography, computed tomographic coronary angiography, myocardial perfusion scan, and angiography), with normal biomarker levels. This definition included patients with new symptoms or a changing symptom pattern (i.e., from stable to unstable angina). Patients with equivocal ECG changes but clear positive changes on exercise tolerance testing or imaging evidence of critical coronary stenosis also were classified as having unstable angina pectoris.
Emergency revascularization was defined as percutaneous coronary intervention or coronary artery bypass grafting in a symptomatic patient, in which the clinical status included either ischemic dysfunction (ongoing ischemia despite maximal medical therapy, acute evolving myocardial ischemia within 24 hours before intervention, or pulmonary edema requiring intubation) or mechanical dysfunction (shock with or without circulatory support). Urgent revascularization included percutaneous coronary intervention or coronary artery bypass grafting that did not meet the emergency criteria above but was required during the same hospitalization. Elective revascularization was not included in the endpoint.
Data Analysis
Data were analyzed using Stata version 14 (StataCorp, 2015) . Baseline characteristics of patients were reported by ECG category. The proportion of patients in each ECG category who were diagnosed with MACE at 30 days or who were deceased at 1 year was reported. The likelihood ratio for MACE was also computed for each ECG category.
To identify whether there were differences in MACE rates by category of ECG, two sets of logistic regression analysis were performed. First, MACE rates were regressed on ECG category. Second, MACE rates were regressed on ECG category after controlling for age (dichotomized at 65 years), sex, hypertension, dyslipidemia, current smoking, diabetes, and family history of CAD. These variables were chosen a priori as they represent the main risk factors for ACS. For both analyses, the odds ratios (ORs) for each ECG category were reported and Wald tests were used to compare parameters for each increasing category of ECG. The purpose of the multivariate model was covariate adjustment rather than development of a predictive model. Thus, the direct-entry method was used where all predictors were entered simultaneously into the model. Eighty-nine patients in this cohort had multiple admissions outside of the 45-day exclusion period. To account for potential nonindependence of such patients within the regression model, logistic regression analyses were conducted using generalized estimating equations with an exchangeable correlation and robust standard errors. Such modeling yielded the same confidence interval (CI) coverage to the traditional model utilizing independent standard errors. Model fit was assessed using the Hosmer-Lemeshow goodness-of-fit test. A check for model assumptions identified no issues with multicollinearity (VIF < 1.5 for all variables), no outlying residuals, and no cases exerting large influence on the model. Kaplan Meier curves were generated to compare time to death across ECG categories and the log-rank test was used to compare survival functions. As there were few deaths in the overall cohort, several of the ECG categories were pooled. ECG categories 2 and 3 were pooled to represent nonspecific ECG abnormalities. Categories 5 and 6 also were pooled to represent the group of patients presenting with ECG findings suggestive of new-onset ischemia. Hazard ratios and 95% CIs were calculated for the combined ECG categories. Statistical significance was set at p < 0.05 for all analyses.
RESULTS
The sample included 2,353 patients; 1,413 (60.3%) were men and the mean age was 52.6 years. Demographic data of the cohorts for each ECG classification is presented in Table 2 . MACE occurred in 264 (11.3%) patients. Within 30 days, T1MI occurred in 148 (6.3%) patients and T2MI occurred in 59 (2.5%) patients. Table 3 displays rates of 30-day MACE, T1MI, and T2MI in emergency patients with chest pain stratified according to the presenting ECG. Logistic regression analysis of 30-day MACE rates according to ECG category (Table 4) showed that the unadjusted and adjusted odds of MACE were higher for ECG category 2 compared to category 1 (p < 0.01 for both). The unadjusted and adjusted odds of MACE did not differ in ECG categories 2 and 3 (p = 0.83 and p = 0.46, respectively), but did increase with increasing ECG category from 3 to 4 (p = 0.01 and p = 0.04, respectively) and 4 to 5 (p < 0.01 for both). The unadjusted and adjusted odds of MACE were similar for category 5 and 6 (p = 0.22 and p = 0.11). The overall multivariate model provided a good fit to the data (Hosmer-Lemeshow v 2 = 9.96, p = 0.27). Figure 1 displays rates of T1MI and T2MI by ECG category.
A total of 1,893 (80.7%) patients agreed to be followed up at 1 year and 31 (1.6%) of these were deceased within the year. The log rank test for equality of survivor functions revealed that mortality differed across ECG categories (p = 0.02; Figure 2) ; patients with nonspecific abnormalities (HR = 3.06, 95% CI: 1.4-6.7, p < 0.01) had higher mortality than patients with normal ECGs. The log-ran test indicated that patients with new ischemia had higher mortality than patients with normal ECGs (p = 0.02), but the hazard ratio (HR) did not reach significance (HR = 3.4, 95% CI = 0.9 to 12.4). Mortality was similar across all other categories.
DISCUSSION
Our study has a number of important findings. First, as expected, increasing degrees of ischemic ECG abnormalities in the presenting ECG were generally associated with increasing risk of MACE. This held true when comparing all ECG categories except categories 2 with 3 and 5 with 6. Per the standardized reporting criteria, the ECGs in group 2 were those ECGs that were an "Accepted deviation from the norm, with the lowest likelihood of ischemia (e.g., inverted T-wave axis in III or V1)." Such changes have previously been described as a normal variant 15 and can appear transiently with respiration and anxiety and in the postprandial state. 16 However, patients with category 2 ECGs experienced MACE at a rate double that of patients with normal ECGs and were comparable with rates in category 3. Furthermore, MACE remained significantly more likely in patients with category 2 ECGs after adjustment for cardiac risk factors. This suggests that, in a patient with chest pain, it may be inappropriate to consider such changes a normal variant. Previous studies of patients with nonspecific ST-T-wave inversion in the asymptomatic population have found higher rates of long-term cardiovascular mortality. [17] [18] [19] These nonspecific ST-T changes may therefore represent subtle ischemia and may identify a higher risk group.
Second, our study adds to the understanding of ECG findings in patients with T2MIs. Half of the patients with T2MI were in category 3-abnormal ECGs not diagnostic of ischemia. These findings highlight that clinicians should be aware of the possibility of a T2MI in a patient with nonspecific, nonischemic ECG changes. ST-segment elevation was rare in patients diagnosed with T2MI in our study, occurring in only one case. This reinforces the need for emergency angiography for patients with such ECG findings to enable revascularization to occur. Overall, our findings are consistent with the literature; 7, 8, 20 however, uniformity of study findings has been hampered by a lack of strict diagnostic criteria for T2MI. Considerable variation in T2MI diagnosis rates has been reported. 21 In this study, a cardiologists' adjudication based on all clinical data at 30 days was used as a "criterion standard," which is consistent with the approach of other articles in the area. Third, findings from this study reinforce the fact that a normal ECG does not rule out the diagnosis of ACS; 5.0% of patients presenting with chest pain and a normal ECG experienced a MACE. A normal ECG identified a lower-risk group, and as such may be useful in early risk stratification of chest pain patients to appropriate assessment protocols. Increasing ECG abnormalities correlated with the presence of cardiac risk factors, and so it could be suggested that these ECG changes simply acted as a proxy for these factors. However, with adjustment of ORs for cardiac risk factors, ECG changes remained an independent predictor of MACE. These findings are consistent with other studies of ECG changes in patients presenting with chest pain. 2, 9 Accelerated diagnostic protocols are being increasingly utilized by EDs to facilitate more rapid diagnosis and treatment of patients with possible ACS. The HEART score, 22 a validated 23 ADP for patients with possible ACS and no ST-elevation, utilizes three ECG groups, which are assigned an increasing risk score. In this study, these three groups correlated approximately with the category 1, categories 2 and 3 combined, and categories 4 and 5 combined. These groups correlated with increasing risk for MACE and our findings thus support this approach. Many other validated ADPs, such as ADAPT, 12 EDACS, 24 and TRUST-ADP 25 utilize a "nonischemic ECG" criterion, where an ECG classified in categories 4,,5 or 6 prevents a patient being considered low risk. Our findings support this approach, with high rates of MACE in these categories. This binary classification is simple to incorporate into treatment protocols, but fails to account for the increased risk conferred by minimally abnormal ECGs. Finally, ischemic ECG abnormalities were correlated with increased 1-year mortality compared to patients with a normal ECG. However, mortality rates were low across all ECG categories. Even patients presenting to the ED with ECG changes of new ischemia had 1-year survival rates of 97%. These findings are consistent with the published data. 4 
LIMITATIONS
The presenting ECG was used in adjudication of endpoints raising the possibility of incorporation bias. An ECG with evidence of ischemia is likely to weight endpoint adjudication in favor of a diagnosis of T1MI and unstable angina pectoris. This could result in artificially elevated rates of MACE for categories 5 and 6. This incorporation bias should be mitigated by adjudication of all clinical, laboratory, and investigation data at 30 days. ECG changes of categories 1, 2, 3, and 4 did not influence the adjudication of endpoints and thus will not be susceptible to this bias. The criteria used for classification of ECGs in category 6 (consistent with AMI) include new or presumed new ST-segment elevation at the J-point in two or more contiguous leads with the cutoff points greater than or equal to 0.2 mV in leads V1, V2, or V3 or greater than or equal to 0.1 mV in other leads in line with previously outlined ECG categories. 11 As such, this category is not identical to the recent American Heart Association (AHA) criteria for STEMI that require only 0.15 mV of ST-elevation in leads V2-V3 in women and, in both sexes, only 1 mV of ST-elevation in lead V1. Additionally STEMI equivalents (such as De Winters T-waves) and changes not meeting the specified criteria were not included in group 6. These differences would be expected to alter the diagnosis in only a small number of cases.
ECGs were classified by cardiologists and not by the treating emergency physicians; however, expert emergency physician and cardiology readings are largely similar. 26, 27 We reported on the findings of the initial ECG and not serial ECGs for this study. In clinical practice the finding of dynamic ECG changes correlates with risk for ACS and this phenomenon could not be explored. Our classification of ECGs differed from that reported by Forest et al. 2 in category 2, and thus these groups cannot be compared. The categories are otherwise similar. Category 4 (ischemia known to be old) required access to prior ECG. In the absence of a prior ECG, any abnormalities were considered to be new. This may have resulted in misclassification of patients in categories 4 and 5. We did not collect data on the number of patients who had a prior ECG available and so the extent of this misclassification is unclear. In addition, for patients with T2MI and nonspecific ECG changes, we are unable to define the number of patients in whom this was a preexisting abnormality.
This was an analysis of observational data; thus, no definitive conclusions can be drawn regarding causality. The observational nature of the data also means that there may be unmeasured confounding variables that may alter the conclusions of this study. Finally, additional validation of the multivariate logistic regression would lend greater generalizability to these findings.
CONCLUSIONS
The risk of major adverse cardiac events, Type 1 myocardial infarction, and 1-year death can be stratified according to standardized electrocardiogram criteria in adults presenting to the ED with chest pain. The electrocardiogram findings in patients with Type 2 myocardial infarction though are variable, and this investigation is less helpful in defining risk of Type 2 myocardial infarction.
